1 – 22 of 22
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
A pilot study on the applicability of thromboelastometry in detecting brain tumour-induced hypercoagulation
(
- Contribution to journal › Article
- 2012
-
Mark
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses
(
- Contribution to journal › Article
-
Mark
Nucleolar proteins with altered expression in leukemic cell lines.
(
- Contribution to journal › Article
-
Mark
Identification of serum biomarker signatures associated with pancreatic cancer
(
- Contribution to journal › Article
- 2011
-
Mark
Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers
(
- Contribution to journal › Article
-
Mark
High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival.
(
- Contribution to journal › Article
- 2010
-
Mark
Diagnostik och uppföljning av patienter med små M-komponenter. Med sikte på att undvika transformation till malign sjukdom.
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Socialstyrelsens riktlinjer för prostatacancersjukvården. Hälsokontroll med PSA-test--bara för välinformerade män.
(
- Contribution to journal › Article
-
Mark
Different assessments of immunohistochemically stained Ki-67 and hTERT in glioblastoma multiforme yield variable results: a study with reference to survival prognosis.
(
- Contribution to journal › Article
-
Mark
Analys av HER2 i bröstcancer kvalitetssäkrad. Viktig behandlingsprediktiv och prognostisk faktor.
(
- Contribution to journal › Article
-
Mark
Systematic review of statistical methods used in molecular marker studies in cancer
(
- Contribution to journal › Article
- 2007
-
Mark
Prostataspecifikt antigen--den viktigaste cancermarkören. Diagnostik och uppföljning av prostatacancer har förändrats markant.
(
- Contribution to journal › Article
- 2006
-
Mark
Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
(
- Contribution to journal › Article
- 2005
-
Mark
LD-isoenzym i uterusaspirat potentiell markör för endometriecancer. Utredning av postmenopausal blödning kan bli enklare och billigare
(
- Contribution to journal › Article
-
Mark
Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project
(
- Contribution to journal › Article
- 2003
-
Mark
High preoperative plasma concentration of tissue plasminogen activator (tPA) is an independent marker for shorter overall survival in patients with ovarian cancer.
(
- Contribution to journal › Article
- 2002
-
Mark
Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
(
- Contribution to journal › Article
-
Mark
Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer.
(
- Contribution to journal › Article
- 2001
-
Mark
The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease
(
- Contribution to journal › Article
- 1999
-
Mark
Quantitative reverse transcription-PCR assay with an internal standard for the detection of prostate-specific antigen mRNA
(
- Contribution to journal › Article
- 1997
-
Mark
Cytogenetic abnormalities and clonal evolution in an adult hepatoblastoma
(
- Contribution to journal › Article
- 1988
-
Mark
Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands
(
- Contribution to journal › Article